How to think about vaccines and patents in a pandemic


Do public-health crises call for a departure from the rules? (The Economist - Business and Finance) More More

Similar stories

Building a More Resilient and Sustainable Health System - AJMC.com Managed Markets Network

Building a More Resilient and Sustainable Health System  AJMC.com Managed Markets Network

Posted on 17 May 2021 | 4:15 pm | Google News

California Coronavirus Updates: Biden Commits To Sharing 80 Million COVID-19 Vaccine Doses Worldwide - Capital Public Radio News

California Coronavirus Updates: Biden Commits To Sharing 80 Million COVID-19 Vaccine Doses Worldwide  Capital Public Radio News

Posted on 17 May 2021 | 2:18 pm | Google News

Covid-19 news: Antibody levels could help predict vaccine efficacy - New Scientist

Covid-19 news: Antibody levels could help predict vaccine efficacy  New Scientist

Posted on 17 May 2021 | 11:12 am | Google News

How to manufacture Covid-19 vaccines without the help of J&J, Pfizer or Moderna? Biolyse sees the difficulties up close - Endpoints News

How to manufacture Covid-19 vaccines without the help of J&J, Pfizer or Moderna? Biolyse sees the difficulties up close  Endpoints News

Posted on 17 May 2021 | 9:41 am | Google News

India's push for COVID vaccine patent waiver hits EU roadblock - DW (English)

India's push for COVID vaccine patent waiver hits EU roadblock  DW (English)

Posted on 17 May 2021 | 9:27 am | Google News

Covid-19: What should we do about B.1.617.2? A classic case of decision making under uncertainty - The BMJ - The BMJ

Covid-19: What should we do about B.1.617.2? A classic case of decision making under uncertainty - The BMJ  The BMJ

Posted on 17 May 2021 | 5:55 am | Google News

Copyright © 2021 LastMinuteStuff.com | Contact info